Esperion Therapeutics
ESPR
#6926
Rank
A$0.72 B
Marketcap
$3.70
Share price
-0.87%
Change (1 day)
-2.04%
Change (1 year)

Esperion Therapeutics (ESPR) - Cash on Hand

Cash on Hand as of September 2024 : A$0.23 Billion

According to Esperion Therapeutics's latest financial reports the company has A$0.23 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Esperion Therapeutics - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.12 B-50.77%
2022-12-31A$0.24 B-31.45%
2021-12-31A$0.35 B-9.81%
2020-12-31A$0.39 B38.3%
2019-12-31A$0.28 B48.52%
2018-12-31A$0.19 B-24.7%
2017-12-31A$0.25 B-12.64%
2016-12-31A$0.29 B0.74%
2015-12-31A$0.29 B125.3%
2014-12-31A$0.12 B92.06%
2013-12-31A$67.33 M974.63%
2012-12-31A$6.26 M308.94%
2011-12-31A$1.53 M
2002-12-31A$79.61 M-42.19%
2001-12-31A$0.13 B9.65%
2000-12-31A$0.12 B1298.01%
1999-12-31A$8.98 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$1.00 B 329.53%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.49 B 542.94%๐Ÿ‡บ๐Ÿ‡ธ USA
A$16.02 B 6,776.87%๐Ÿ‡บ๐Ÿ‡ธ USA
A$15.77 B 6,669.42%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.40 B 72.58%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.41 B 78.53%๐Ÿ‡บ๐Ÿ‡ธ USA